The regulation of the production and catabolism of 1,25(OH)2D has recently been reviewed by Plum and DeLuca. 1 Most, if not all, of the circulating 1,25(OH)2D is produced in the kidney through the action of the enzyme 1-α-hydroxylase (CYP27B1) on 25(OH)D. Hypocalcemia activates the secretion of PTH, which acting on the kidney induces the activity of renal 1-α-hydroxylase leading to increased circulating levels of 1,25(OH)2D. Hypophosphatemia can also activate renal 1-α-hydroxylase by an non-clear mechanism, leading also to increased circulating 1,25(OH)2D. When both serum calcium and serum phosphorus concentrations are low, renal 1-α-hydroxylase is super-stimulated, resulting in extremely high circulating 1,25(OH)2D. 1 The catabolism of 1,25(OH)2D is also regulated to prevent hypercalcemia and hyperphosphatemia. 1 The main catabolic enzyme in the vitamin D endocrine system is 24-hydroxylase (CYP24A1). This enzyme attenuates the vitamin responsiveness by catalyzing synthesis of the inactive metabolites 1,24,25 (OH)3D and 24,25(OH)2D from 1,25(OH)2D and 25(OH)D, respectively. The high PTH during hypocalcemia not only stimulates the production of 1,25(OH)2D but also decreases its catabolism by decreasing 24-hydroxylase activity, thereby repressing the production of 1,24,25 (OH)3D and 24,25(OH)2D. Low serum phosphorus decreases the mRNA levels of the 24-hydroxylase to prevent catabolism of 1,25(OH)2D. Transcription of the 24-hydroxylase gene is stimulated by 1,25(OH)2D and thus 1,25(OH)2D enhances its own catabolism, while PTH has a key control of 24-hydroxylase activity. 1 The best marker of vitamin D status in the adult is considered to be the 25 [8] [9] [10] [11] and cross-sectional 12-14 studies have shown that, when compared to non-pregnant young women, pregnant women have high serum 1,25(OH)2D concentration from early pregnancy; serum 1,25(OH)2D rises steadily throughout gestation and reaches levels about double those of non-pregnant women at term. The contribution of the placenta to the high circulating 1,25(OH)2D is not clear. Human placenta and decidua can synthesize 1,25(OH)2D. Vitamin D receptors (VDR), 1-α-hydroxylase, and 24-hydroxylase are expressed in human placenta and decidua. 15 Zehnder et al 15 demonstrated that the expression of mRNA for 1-α-hydroxylase in decidua was ~1000-fold higher in the first and second trimester when compared with the third trimester of human pregnancy. In placenta, 1-α-hydroxylase expression was 80-fold higher in the first and second when compared with the third trimester biopsies. Therefore, if the placenta were the main source of circulating 1,25(OH)2D one would expect the level of 1,25(OH)2D to be higher during early than late stages of pregnancy, unless the catabolism of 1,25(OH)2D during early pregnancy is much higher than in advanced gestation. Thus, it seems more probable that the 1,25(OH)2D in the maternal circulation originates mainly from the maternal kidneys (see also review by Kovacs). 16 Plasma concentration of vitamin D binding protein (DBP) is high in pregnancy 13 and this, at least partly, accounts for the frankly elevated total 1,25(OH)2D; free serum 1,25(OH)2D was found to be high 13, 17 or normal 18 during pregnancy (see ref. 18 for discussion on free serum 1,25(OH)2D in pregnancy).
The high 1,25(OH)2D serum concentration could theoretically induce some changes in the metabolism of vitamin D during human pregnancy. Halloran and Castro 19 found that chronic 1,25(OH)2D administration in the rat reduced the serum concentration of 25(OH)D by increasing its metabolic clearance rate (MCR) without affecting its production rate (PR). This treatment also increased both the MCR and PR of 24,25(OH)2D. However, the disproportionately larger increase in MCR resulted also in a decrease in the serum concentration of 24,25(OH)2D. 19 The findings of Berlin and Björkhem were similar. 20 Clements et al 21 showed that in rats the hepatic catabolism of 25(OH)D is increased by calcium deprivation and that this effect is mediated by 1,25(OH)2D produced in response to secondary hyperparathyroidism. Administration of 1,25(OH)2D in humans significantly decreased serum 25(OH)D concentration. 22 Davies et al 23 found a significant negative relationship between the elimination half-time (t½) of 
methods
The electronic literature (Medline) was searched using the MeSH terms "pregnancy" and "vitamin D" for studies in pregnant women in which measurements of vitamin D metabolites were included. Twenty studies, comprising 26 groups of pregnant women at term, in which at least two of the vitamin D metabolites 25(OH)D, 1,25(OH)2D, and 24,25(OH)2D were determined, were selected for analysis. The pregnant women of 19 groups did not take vitamin supplements (Table 1A ). The women of 7 groups were supplemented with vitamin D (400 IU/d) during their pregnancy (Table 1B) . Fourteen control groups of young healthy non-pregnant women, of which 9 were part of the pregnancy studies and 5 were from independent studies, were also analyzed (Table 1C) . The means of the parameters from each group of women were analyzed. In the 20 groups of pregnant and 9 groups of non-pregnant women measurements of both 1,25(OH)2D and 25(OH)D were available and thus the relationship of these two metabolites could be evaluated. In the 13 groups of pregnant and 7 groups of non-pregnant women results of both 25(OH)D and 24,25(OH)2D were available for a similar analysis.
Comparison between two means by t test and linear regression of the means of a vitamin D metabolite on the means of a second vitamin D metabolite were performed using GraphPad Prism, GraphPad Software, San Diego, California, USA. Significance was set as a two-tailed p<0.05.
results
The mean of the means (grand mean) of serum 25(OH)D, serum 1,25(OH)2D, and serum 24,25(OH)2D were not significantly different between vitamin D supplemented and unsupplemented pregnant women and thus the two categories of pregnant women were combined into a single category.
The relationship between 1,25(OH)2D and 25(OH)D is shown in Figure 1 . The mean of the means (grand mean) of serum 25(OH)D in pregnant women (n=20 means) was not different from the grand mean (n= 9 means) in non-pregnant controls 
dIscussIon
High 1,25(OH)2D serum levels after administration of 1,25(OH)2D in rats 19, 20 or in humans 22 have been shown to cause a reduction in the serum level of 25(OH)D by increasing its metabolic clearance rate 19 or reducing its t½. 24 Increased catabolism of 25(OH)D was demonstrated after inducing high levels of endogenous 1,25(OH)2D by low calcium diet in rats. 21 Clements et al 24 High serum 1,25(OH)2D also induced a fall in serum 24,25(OH)2D in rats, in parallel with the fall in serum 25(OH)D. 19 In patients with partial gastrectomy and high serum 1,25(OH)2D, serum 24,25(OH)2D was found to be significantly lower than in controls. 44 In the 13 groups of pregnant and 7 groups of non-pregnant women, both mean serum 25(OH)D and mean serum 24,25(OH)2D were available for analysis. The grand mean of serum 25(OH)D was significantly lower in pregnant than in control women. The grand mean of serum 24,25(OH)2D was also lower in the pregnant women, although not significantly. However, the grand means of the 24,25(OH)2D/25(OH)D ratio in pregnant and control women were not different (Figure 2) . Regression of the means of serum 24,25(OH)2D on the means of serum 25(OH)D showed a significant relationship between the two vitamin D metabolites in pregnant women and almost significant relationship in the controls. The regression coefficients indicated that 42% of the variation of the means of serum 24,25(OH)2D could be explained by changes in the means of serum 25(OH)D in pregnant women, and 49% of the vari- 1 This meta-analysis showed that serum 1,25(OH)2D is not related to serum 25(OH)D, whereas by contrast serum 24,25(OH)2D is significantly related to serum 25(OH)D in both pregnant and non-pregnant young women. These findings allow the conclusion that in human pregnancy the high serum levels of 1,25(OH)2D do not seem to induce changes in the metabolism of 24,25(OH)2D, while for a possible effect of high 1,25(OH)2D on 25(OH)D a similar conclusion is less clear. The best method to resolve this matter is probably the measurement of the elimination half-time of serum 25(OH)D in pregnant women, using the method employed by Clements et al 20, 24 In the majority of the studies analyzed here, mean serum 1,25(OH)2D in pregnant women was high (>138 pmol/L), while mean serum 25(OH)D was less than 50 nmol/L, and in three studies less than 25 nmol/L. Only in one study 30 did pregnant women with severe vitamin D deficiency [extremely low 25(OH)D] have relatively low serum 1,25(OH)2D. Consequently, it seems uncertain whether many pregnant women with low serum 25(OH)D but high serum 1,25(OH)2D may be characterized as vitamin D deficient. On the other hand, among the studies herein analyzed, only in one study 34 was mean serum 25(OH)D above 80 nmol/L and in this case mean serum 1,25(OH)2D was not unusually high for pregnant women (see Table  1 and Figure 1) . Therefore, it is not possible from these data to predict 1,25(OH)2D serum levels when 25(OH)D serum levels are frankly above 80 nmol/L during pregnancy.
Among the limitations of this meta-analysis are the limited number of the analyzed studies, the heterogeneity of the studied populations, and the variable methods used for the measurements of the vitamin D metabolites.
Possible mechanisms responsible for the high serum 1,25(OH)2D in pregnancy have been proposed (see review by Kovacs) . 16 In two longitudinal studies, 10,46 the true percentage of calcium absorption was found to be higher in pregnant women with low 46 compared to pregnant women with high calcium intake. 10 Then again, urinary excretion of calcium increased during pregnancy in women with high calcium intake, 10 but decreased in women with low calcium intake. 46 Therefore, it seems that calcium homeostasis can adapt to low calcium intake during pregnancy. 46 The mechanism for this adaptation is not understood, and the role of the high 1,25(OH)2D serum levels in the increased intestinal absorption of calcium during pregnancy has not been determined. 16, 46 Many hormones such as PTH, estrogens, prolactin, and human placental lactogen may apparently be involved in the regulation of calcium homeostasis in pregnancy, while it has been suggested that vitamin D does not have an important role in the increased intestinal calcium absorption during pregnancy. 16 The possibility that the hypercortisolism of pregnancy 47 may be a cause of some degree of vitamin D resistance and the effects on calcium homeostasis of the chronic respiratory alkalosis 48 commonly affecting pregnant women should also be considered.
In conclusion, it is not clear whether vitamin 16 we consider that there is need for prospective studies with large numbers of pregnant women to elucidate whether the same criteria established for the definition of vitamin status in the non-pregnant adults can also be applied to pregnant women. 
